Kyrgyzstan vs Solomon Islands: Prevalence of anemia among women of reproductive age
Kyrgyzstan
32.9%
in 2023
Solomon Islands
32.6%
in 2023
Kyrgyzstan rank
54th
Solomon Islands rank
57th
Prevalence of anemia among women of reproductive age over time
- Kyrgyzstan
- Solomon Islands
How they compare
Kyrgyzstan currently reports 32.9% against 32.6% in Solomon Islands, a difference of 0.3%.
Across all 24 years both countries report, Kyrgyzstan has been ahead every year.
Kyrgyzstan ranks 54th and Solomon Islands ranks 57th of 192 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.8% | 30.8% | 5.0% | Kyrgyzstan |
| 2010s | 33.5% | 29.8% | 3.6% | Kyrgyzstan |
| 2020s | 32.7% | 31.7% | 1.1% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Kyrgyzstan or Solomon Islands?
- Kyrgyzstan, at 32.9% against 32.6% in Solomon Islands as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Kyrgyzstan and Solomon Islands?
- 0.3%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Solomon Islands?
- 24 years are reported by both, from 2000 to 2023.
- How do Kyrgyzstan and Solomon Islands rank globally for prevalence of anemia among women of reproductive age?
- Kyrgyzstan ranks 54th and Solomon Islands ranks 57th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.